Forecast of antibiotic susceptibility of translocating strains of enterobacteria and pseudomonas in leukemic neutropenic patients.
D000380:Agranulocytosis / Q000382:microbiology*; D000583:Amikacin / Q000494:pharmacology; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002439:Cefotaxime / Q000494:pharmacology; D004755:Enterobacteriaceae / Q000187:drug effects*; D005243:Feces / Q000382:microbiology; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007938:Leukemia / Q000150:complications*; D008826:Microbial Sensitivity Tests; D009503:Neutropenia / Q000209:etiology / Q000382:microbiology*; D011549:Pseudomonas / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000667:Ampicillin; D000583:Amikacin; D002439:Cefotaxime